Biotech MavenTrending NewsTwo Notable Late Analyst Calls For Wednesday, July 11thBiotech MavenCantor Fitzgerald Reaffirms Their Buy Rating on Corium - MarketsIn a report released today, William Tanner from Cantor Fitzgerald reiterated a Buy rating on Corium (NASDAQ: CORI), with awww.markets.co